Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5260-5267
Author(s):
Yanyan Pan, Mei Meng, Gaochuan Zhang, Hongyan Han and Quansheng Zhou
MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
459-467
Author(s):
Marco Rossi, Nicola Amodio, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone and William C. Cho
New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Journal:
Current Drug Targets
Volume:
15
Page:
843-851
Author(s):
Spiros Vlahopoulos, Elena Critselis, Ioannis F. Voutsas, Sonia A. Perez, Maria Moschovi, Constantin N. Baxevanis and George P. Chrousos
Tumor Dormancy and the Angiogenic Switch: Possible Implications of Bone Marrow- Derived Cells
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4920-4933
Author(s):
Yuval Shaked, Sandra McAllister, Ofer Fainaru and Nava Almog
Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3173-3187
Author(s):
J. Zhu, M. Wang, B. Cao, T. Hou and X. Mao
A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3153-3164
Author(s):
G. Bronzetti, A. Patrizi, F. Giacomini, F. Savoia, B. Raone, M. Brighenti, M. Bonvicini, I. Neri and G.D. Gargiulo
IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3042-3047
Author(s):
I. Kolosenko, D. Grander and K.P. Tamm
Heat Shock Protein 90 Inhibitors in Oncology
Journal:
Current Proteomics
Volume:
11
Page:
2-16
Author(s):
Aykut Ozgur and Yusuf Tutar
Is Helicobacter pylori Always a "Bad Guy"?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4517-4520
Author(s):
Iva Hojsak and Sanja Kolacek
From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
434-445
Author(s):
Koramit Suppipat and H. Daniel Lacorazza